Effect of Probiotic (VSL#3) and Omega-3 on Lipid Profile, Insulin Sensitivity, Inflammatory Markers, and Gut Colonization in Overweight Adults: A Randomized, Controlled Trial
Table 2
Fecal bacterial count before and after treatment.
Placebo
Probiotic
Omega-3
Pro + Omega-3
Pretreatment
Posttreatment
Pretreatment
Posttreatment
Pretreatment
Posttreatment
Pretreatment
Posttreatment
Total bacteria
7.74 ± 0.21
7.71 ± 0.18a
8.77 ± 0.09
9.13 ± 0.18*b
7.7 ± 0.19
7.78 ± 0.16a
8.83 ± 0.09
9.55 ± 0.12**b
Total anaerobes
9.32 ± 0.17
9.27 ± 0.12a
9.66 ± 0.06
10.71 ± 0.07**b
9.44 ± 0.18
9.54 ± 0.09a
9.61 ± 0.1
10.86 ± 0.05**b
Lactobacillus
6.87 ± 0.12
6.86 ± 0.14a
6.77 ± 0.1
7.95 ± 0.13**b
6.76 ± 0.26
6.8 ± 0.12a
6.76 ± 0.12
7.96 ± 0.12**b
Bifidobacteria
8.89 ± 0.17
8.88 ± 0.14a
8.71 ± 0.11
9.94 ± 0.01**b
8.71 ± 0.08
8.75 ± 0.17a
8.71 ± 0.08
9.9 ± 0.03**b
Streptococcus
2.81 ± 0.21
2.80 ± 0.31a
2.66 ± 0.1
8.96 ± 0.16**b
2.67 ± 0.19
2.89 ± 0.29a
2.67 ± 0.11
8.99 ± 0.13**b
Coliform
6.82 ± 0.19
6.83 ± 0.13a
6.59 ± 0.1
6.35 ± 0.2a
6.54 ± 0.13
6.44 ± 0.12a
6.99 ± 0.14
6.58 ± 0.11**a
E.coli
6.59 ± 0.14
6.93 ± 0.19**a
6.58 ± 0.09
6.47 ± 0.13b
6.55 ± 0.18
6.53 ± 0.09a
6.69 ± 0.19
6.39 ± 0.09b
Bacteroides
6.61 ± 0.19
6.98 ± 0.15**a
6.99 ± 0.18
7.57 ± 0.17**b
6.59 ± 0.1
6.45 ± 0.25c
6.96 ± 0.15
7.87 ± 0.11**d
<0.05 significantly different from the pretreatment level.
**<0.01 significantly different from the pretreatment level.
a,b,c,dSuperscript indicates significant <0.05 difference in relative changes versus baseline compared between supplemented and placebo group. Bacterial count ( CFU/g fecal dry weight ± standard error mean).